As a result, the upregulation in expression of STAT2 mRNA was observed in KIRC patients compared to the normal healthy persons in the sub-group analyses based on sample types, race, gender, age, KIRC subtypes, tumor grade, cancer stages, and nodal metastasis status (Fig. 2A). The gene discussed is STAT2; the disease is cancer.